Member Info for mol42

We’re attending 28-30 Oct 25

Profile

https://www.cphi-online.com/company/probiotix-health/

mol

Heart Health:

Cardiovascular health is the next frontier in microbiome benefits and new strains have emerged that deliver big benefits, says Cellan Davies, Head of Marketing, ProBiotix Health. “One standout example is LPLDL, a patented strain of Lactobacillus plantarum, clinically shown to reduce cholesterol, ApoB, blood pressure and triglycerides, which are all critical markers for cardiometabolic health. Several human intervention studies demonstrate the ability of LPLDL to modulate bile salts via the gut-liver axis, which can lead to significant reductions in LDL cholesterol, Apolipoprotein B, and blood pressure. These aren’t just theoretical benefits, but measurable outcomes supported by rigorous science.” ProBiotix offers LPLD in tri-layer tablets that preserve the live probiotic while combining it with synergistic cardiovascular actives like CoQ10 or vitamin K2 and in InstaMelt powder, which dissolves directly on the tongue without the need for water for optimal consumer.

https://www.wholefoodsmagazine.com/articles/17690-biotics-trends-driving-demand-in-2026

mol

Issued share capital: 228,435,909 Ordinary Shares of 1p nominal value at Dec 2024

Significant Shareholders
 as at 19 December 2024 that hold more than 3% of the share capital of SkinBioTherapeutics plc are detailed below:

OptiBiotix Health Plc 21,884,389 9.58%

Tyndall Investment Management 18,357,826 8.04%

Seneca Partners Limited 14,274,578 6.25%

David Brierwood 9,347,929 4.09%

The University of Manchester 8,000,000 3.50%

Unicorn Asset Management 7,894,737 3.46%

and the voting was

ResolutionNumber VotesFor VotesAgainst VotesWithheld VotesTotal

1 69,573,553 1,912,516 102,004 71,588,073

2 69,726,751 1,694,065 167,257 71,588,073

3 70,755,199 821,439 11,435 71,588,073

4 70,054,879 1,423,957 109,237 71,588,073

5 69,828,423 1,436,868 322,782 71,588,073

6 70,020,630 1,371,968 195,475 71,588,073

7 70,168,430 1,222,168 197,475 71,588,073

8 67,873,014 2,222,318 1,492,741 71,588,073

9 67,713,745 3,794,922 79,406 71,588,073

10 66,787,404 4,721,263 79,406 71,588,073

11 66,780,617 4,728,050 79,406 71,588,073

a welcome number opposed to the special resolutions 10 and 11 (need 75% majority) but still nowhere near enough

a touch of reality perhaps - not every retail investor reads this bb/other bbs nor follows other subscription channels and even then

as noted here not everyone agrees with the views of some of the most vocal

bit like life generally

mol

Dermatonics uk recent reviews encouraging

https://www.trustpilot.com/review/dermatonics.co.uk

let's hope the sales show a distinct improvement as well in the second 6 months

mol

Has certainly been upping the articles in September

https://pheet.co.in/blogs/news

just a bit of info

mol

Not me and never will along with that other frequently mentioned prophet on this bb

yep you got to laugh

mol

Directors and others

30 may 2025

Steen 124550 £9823

Adam 50000 £3940

M Brandt 188945 £14790

M Collingbourne 108907 £7896

M Liticheski 76780 £5494

that's it - delivered as promised - albeit hardly breathtaking amounts at time as i noted

mind as interim results out - nowt stopping them from investing again albeit this time perhaps showing more confidence in the words as noted in interims and investing more of their salaries in our company

mol

Https://seed.com/cultured/probiotics-cholesterol-heart-health-support-guide/

mol

Last time voting

https://www.unicornam.com/wp-content/uploads/bsr-12m-comb-significant-voting.pdf

mol

Bit more

Bring down skin premature ageing by improving emotional resilience: an innovative Lactobacillus extract as a neuro-cosmetic ingredient

18/09/2025 | 08:30 - 17:00 | Foyer Debussy

Code: POSTER_S6_ZONE_F_IFSCC2025-424

Topic: Neuro/Sensory sciences/emotions

Description:

Please display your poster all day (8h30 - 17h00) and collect it by the end of the day (17h30 latest).

Authors are asked to be present in front of their poster at least during the following times:

Lunch Break: 12h10 - 13h30

Afternoon Break: 14h55 - 15h20

Abstract: IFSCC2025-424 ( View authors' details)

Speaker(s): Alba Cico (France)

and full list of authors

N° IFSCC2025-424

Bring down skin premature ageing by improving emotional resilience: an innovative Lactobacillus extract as a neuro-cosmetic ingredient

Authors:

Alba Cico* 1, Marie Berthy1, Carole Le Bachelier1, Maeva Godet1, Emmanuel Doridot1, Caroline Ringenbach1, Cecile Jonchier1, Jasmine Leong2, Magali Bonnier3, Alex Saunois1, Philippe Mondon1

1Croda Beauty Actives, Le Perray en Yvelines , France, 2Croda Beauty Actives, Singapore, Singapore, 3Croda Beauty Actives, Montigny Le Bretonneux, France

mol

We are pleased to announce that the Croda Beauty Actives team will participate in the 35th IFSCC Congress with a poster presentation entitled:

“Bring down skin premature ageing by improving emotional resilience: an innovative Lactobacillus extract as a neuro-cosmetic ingredient”

Our research highlights the strong connection between stress, skin ageing, and emotional well-being, and how innovative neuro-cosmetic solutions can help support resilience and beauty from within.

The team looks forward to sharing insights with the global cosmetic science community and driving innovation in skin health and well-being.

Zone F Thursday 18th Sep

IFSCC2025-424 • Bring down skin premature ageing by improving emotional resi-

lience: an innovative Lactobacillus extract as a neuro-cosmetic ingredient

https://ifscc2025.com/upload/programme/IFSCC25---Poster-Program-Online.pdf

mol

Easy to miss this bit after ends

About SkinBiotherapeutics plc

SkinBiotherapeutics is a life science company focused on skin health. The Group's proprietary platform technology, SkinBiotix®, is based upon discoveries made by the translational dermatology team at the University of Manchester.

The Group's foundation business is targeting the skin healthcare market via five pillars, the most advanced of which are cosmetic skincare (SkinBiotix) and food supplements to modulate the immune system by harnessing the gut-skin axis (AxisBiotix). The cosmetic pillar has a partnership with Croda plc and the Group's first in-house product, AxisBiotix-Ps™, is a food supplement to address the symptoms of mild to moderate psoriasis.

The Group is also acting as a consolidator and is making acquisitions in complementary areas such as skin care and cosmetic applications, that also bring new distribution and geographical platforms, and manufacturing capabilities through which it can funnel its in-house pillar products.

The Company listed on AIM in April 2017 and is based in Newcastle, UK.

For more information, visit: www.skinbiotherapeutics.com

SkinBiotheraputics plc: +44 (0) 191 495 7325

mol

New video

https://www.gcimagazine.com/brands-products/skin-care/video/22949155/croda-inc-zenakine-the-beauty-ingredient-that-makes-you-smile-literally

mol

Doesn't say much for Emily as company secretary nor of course our Chairman re governance

mol

Still not updated

https://www.skinbiotherapeutics.com/investor-relations/board-of-directors/

and no update here either

https://www.skinbiotherapeutics.com/wp-content/uploads/2023/10/Corporate-Governance-Report-Sep-2023.pdf

mol

Https://d197for5662m48.cloudfront.net/documents/publicationstatus/271968/preprint_pdf/5b1149de41093ec109306b2bd036142b.pdf

https://d197for5662m48.cloudfront.net/documents/publicationstatus/272432/preprint_pdf/900dc3394706c9b1f177769a76408197.pdf

the first notes a reference

Zenakine : A biotechnology-based peptide, it induces “feel-good messengers,” improving sleep, mood,

and stress resilience, reducing fatigue and aging signs (Mistur et al., 2024).

which refers to 2024 - unfortunately i wasn't able to find said reference which purportedly refers to zenakine in 2024 or at least the paper of same

anyway a bit on reza

https://orcid.org/0009-0004-1745-1315

and publications

https://essopenarchive.org/users/946270?articles_format=grid&view_mode=publications

mol

Generally now an umbrella term attached to many forms of diminutive potted plants

mol

Best wishes nick

mol

Https://www.youtube.com/watch?v=n6TTC3QjtP8

In this episode of The Mind-Gut Conversation, I sit down with Dr. Zain Kassam, Chief Medical Officer at Seed Health and a pioneer in the field of microbiome therapeutics. If you’ve ever been curious about how probiotics work, how to choose a high-quality supplement, or whether they actually do more than your diet already provides—this is the episode you’ve been waiting for.

In this conversation, we explore:

• Why the probiotic market is booming—and how Seed Health is setting a new scientific standard.

• The critical differences between synbiotics, probiotics and naturally fermented foods.

• Are most probiotics backed by real science, or is the supplement industry skipping clinical rigor?

• Can probiotics actually go beyond a healthy diet to offer additional health benefits?

• How to navigate the sea of probiotic options: what to look for, what to avoid and what actually matters.

Dr. Kassam brings a rare blend of scientific depth and real-world experience. He received his MPH from Harvard, completed post-doctoral training at MIT, and has co-founded two foundational microbiome companies—OpenBiome and Finch Therapeutics—before joining Seed.

His work has redefined the role of the microbiome in medicine, from establishing the first public stool bank to exploring bioengineered probiotics for chronic disease.

just stumbled across this podcast this evening and something to listen to over the weekend perhaps

mol

Methinks i was one of the first to question decisions taken by SA and MR and their remuneration etc - long before your posts baz - and before the turnabout of some very vocal posters /supporters now questioning, presumably, the decision they took in investing here and are now castigating SA

jees wasn't that long ago they were castigating me - lol

sometimes it just pays to read and consider another viewpoint without resorting to a diatribe of abuse

just like now - as it was then

over the top speculation and largely drivel

mol